Cargando…

Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology

The aim of the investigation was to study the potential of an innovative microfluidic technology for the isolation of circulating tumor cells (CTCs) from the peripheral blood samples of cancer patients. MATERIALS AND METHODS. Peripheral blood samples from 5 patients with disseminated malignant tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Volovetskiy, A.B., Malinina, P.A., Kapitannikova, A.Y., Smetanina, S.V., Kruglova, I.A., Maslennikova, A.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Privolzhsky Research Medical University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596232/
https://www.ncbi.nlm.nih.gov/pubmed/34796020
http://dx.doi.org/10.17691/stm2020.12.6.08
_version_ 1784600318218076160
author Volovetskiy, A.B.
Malinina, P.A.
Kapitannikova, A.Y.
Smetanina, S.V.
Kruglova, I.A.
Maslennikova, A.V.
author_facet Volovetskiy, A.B.
Malinina, P.A.
Kapitannikova, A.Y.
Smetanina, S.V.
Kruglova, I.A.
Maslennikova, A.V.
author_sort Volovetskiy, A.B.
collection PubMed
description The aim of the investigation was to study the potential of an innovative microfluidic technology for the isolation of circulating tumor cells (CTCs) from the peripheral blood samples of cancer patients. MATERIALS AND METHODS. Peripheral blood samples from 5 patients with disseminated malignant tumors of epithelial origin were processed with the use of the microfluidic technology (based on a specifically designed silicone chip). The cells were separated according to their density criterion based on the lateral migration of solid particles in a liquid due to inertial forces. With the help of the designed chip configuration, the cells over 13 μm in size which is larger than the standard size of blood cells were isolated. The resulting target cell fraction was stained by the Romanowsky–Giemsa method. Staining with the fluorescent Anti-Cytokeratin (CK3-6H5)-FITC antibody was carried out to confirm the epithelial nature of the cells, and the DAPI dye was used to contrast the nucleus. The blood of a healthy volunteer and tumor cells of the A549 line were used for the immunocytochemical studies. RESULTS. The tumor cells in peripheral blood (in the number of 1 to 9) were detected in all 5 patients. CTC clusters of 2–5 cells were identified in blood samples from the patients with laryngeal cancer, non-small cell lung cancer, and floor of the mouth cancer. A bright saturated staining of the A549 tumor cells was obtained using the Anti-Cytokeratin (CK3-6H5)-FITC antibody, corresponding to the staining of the cytoskeleton of epithelial cells. Successful nuclear staining with DAPI confirmed that the isolated target cells are not damaged during microfluidic separation. CONCLUSION. The microfluidic technology that has been used enables effective intact CTCs isolating from the peripheral blood of cancer patients. The epithelial nature of the isolated cells can be confirmed by immunocytochemical studies.
format Online
Article
Text
id pubmed-8596232
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Privolzhsky Research Medical University
record_format MEDLINE/PubMed
spelling pubmed-85962322021-11-17 Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology Volovetskiy, A.B. Malinina, P.A. Kapitannikova, A.Y. Smetanina, S.V. Kruglova, I.A. Maslennikova, A.V. Sovrem Tekhnologii Med Biotechnologies The aim of the investigation was to study the potential of an innovative microfluidic technology for the isolation of circulating tumor cells (CTCs) from the peripheral blood samples of cancer patients. MATERIALS AND METHODS. Peripheral blood samples from 5 patients with disseminated malignant tumors of epithelial origin were processed with the use of the microfluidic technology (based on a specifically designed silicone chip). The cells were separated according to their density criterion based on the lateral migration of solid particles in a liquid due to inertial forces. With the help of the designed chip configuration, the cells over 13 μm in size which is larger than the standard size of blood cells were isolated. The resulting target cell fraction was stained by the Romanowsky–Giemsa method. Staining with the fluorescent Anti-Cytokeratin (CK3-6H5)-FITC antibody was carried out to confirm the epithelial nature of the cells, and the DAPI dye was used to contrast the nucleus. The blood of a healthy volunteer and tumor cells of the A549 line were used for the immunocytochemical studies. RESULTS. The tumor cells in peripheral blood (in the number of 1 to 9) were detected in all 5 patients. CTC clusters of 2–5 cells were identified in blood samples from the patients with laryngeal cancer, non-small cell lung cancer, and floor of the mouth cancer. A bright saturated staining of the A549 tumor cells was obtained using the Anti-Cytokeratin (CK3-6H5)-FITC antibody, corresponding to the staining of the cytoskeleton of epithelial cells. Successful nuclear staining with DAPI confirmed that the isolated target cells are not damaged during microfluidic separation. CONCLUSION. The microfluidic technology that has been used enables effective intact CTCs isolating from the peripheral blood of cancer patients. The epithelial nature of the isolated cells can be confirmed by immunocytochemical studies. Privolzhsky Research Medical University 2020 2020-12-28 /pmc/articles/PMC8596232/ /pubmed/34796020 http://dx.doi.org/10.17691/stm2020.12.6.08 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Biotechnologies
Volovetskiy, A.B.
Malinina, P.A.
Kapitannikova, A.Y.
Smetanina, S.V.
Kruglova, I.A.
Maslennikova, A.V.
Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology
title Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology
title_full Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology
title_fullStr Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology
title_full_unstemmed Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology
title_short Isolation of Circulating Tumor Cells from Peripheral Blood Samples of Cancer Patients Using Microfluidic Technology
title_sort isolation of circulating tumor cells from peripheral blood samples of cancer patients using microfluidic technology
topic Biotechnologies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596232/
https://www.ncbi.nlm.nih.gov/pubmed/34796020
http://dx.doi.org/10.17691/stm2020.12.6.08
work_keys_str_mv AT volovetskiyab isolationofcirculatingtumorcellsfromperipheralbloodsamplesofcancerpatientsusingmicrofluidictechnology
AT malininapa isolationofcirculatingtumorcellsfromperipheralbloodsamplesofcancerpatientsusingmicrofluidictechnology
AT kapitannikovaay isolationofcirculatingtumorcellsfromperipheralbloodsamplesofcancerpatientsusingmicrofluidictechnology
AT smetaninasv isolationofcirculatingtumorcellsfromperipheralbloodsamplesofcancerpatientsusingmicrofluidictechnology
AT kruglovaia isolationofcirculatingtumorcellsfromperipheralbloodsamplesofcancerpatientsusingmicrofluidictechnology
AT maslennikovaav isolationofcirculatingtumorcellsfromperipheralbloodsamplesofcancerpatientsusingmicrofluidictechnology